On August 24, 2023 Ascendis Pharma A/S (Nasdaq: ASND) reported that Jan Mikkelsen, President & Chief Executive Officer, and Scott Smith, Executive Vice President & Chief Financial Officer, will participate in three upcoming investor conferences (Press release, Ascendis Pharma, AUG 24, 2023, View Source [SID1234634674]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details:

Event Citi’s 18th Annual BioPharma Conference
Location Boston, MA
Date Thursday, September 7, 2023
Time 2:40-3:25 p.m. Eastern Time / 11:40 a.m-12:25 p.m. Pacific Time

Event 2023 Wells Fargo Healthcare Conference
Location Boston, MA
Date Friday, September 8, 2023
Time 8:00-8:35 a.m. Eastern Time / 5:00-5:35 a.m. Pacific Time

Event Morgan Stanley 21st Annual Global Healthcare Conference
Location New York, NY
Date Tuesday, September 12, 2023
Time 12:55-1:25 p.m. Eastern Time / 9:55-10:25 a.m. Pacific Time

A live webcast of the events will be available via the Investors & News section of the Ascendis Pharma website at investors.ascendispharma.com. A webcast replay will also be available on this website shortly after conclusion of the event for 30 days.